Preview

Pediatric pharmacology

Advanced search

PECULIARITIES OF THE FIBROSIS AND CIRRHOSIS MONITORING AMONG CHILDREN WITH CHRONIC LIVER DISEASES

Abstract

The researchers examined the opportunities to use determination in the serum among children with chronic liver diseases of various etiologies of the hyaluronic acid levels, collagen type IV, matrix metalloproteinase-2, tissue inhibitor of the matrix proteinases 1 in diagnostics of the liver fibrosis degree. They have found out that children with the given pathology show significantly growing concentrations of these compounds against marked fibrotic changes in the liver parenchyma. Hyaluronic acid, collagen type IV and matrix metalloproteinase 2 may be reliable noninvasive cirrhosis markers and used to monitor the efficiency of therapy for the chronic liver diseases among children.
Key words: matrix metalloproteinase-2, tissular inhibitor of the matrix proteinases 1, liver cirrhosis, markers, diagnostics, children.

About the Authors

A.N. Surkov
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


I.E. Smirnov
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


A.S. Potapov
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


A.G. Kucherenko
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


E.L. Tumanova
Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation


Review

For citations:


Surkov A., Smirnov I., Potapov A., Kucherenko A., Tumanova E. PECULIARITIES OF THE FIBROSIS AND CIRRHOSIS MONITORING AMONG CHILDREN WITH CHRONIC LIVER DISEASES. Pediatric pharmacology. 2009;6(2):31-34.

Views: 501


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)